John 'Chip' Tilton, MD (image)

Case Western Reserve University

Caption

John "Chip" Tilton, MD, of Case Western Reserve University School of Medicine will receive $300,000 from the Dr. Ralph and Marian Falk Medical Research Trust to develop a virus-based "nanoPOD" (nanoscale PrOtein Delivery) platform to help treat rare genetic diseases. The project will address a major challenge in developing nanoscale therapeutics: finding ways to deliver them to the right location inside the body.

Credit

Case Western Reserve University School of Medicine

Usage Restrictions

None

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.